Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Proof-of-concept Study on Immune Surveillance and Alertness

NCT05431751 is registered in ClinicalTrials.gov with Natural Immune Systems Inc as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05431751 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Proof-of-concept Study on Immune Surveillance and Alertness
Lead sponsor
Natural Immune Systems Inc
Phase
Not applicable
Overall status
Unknown status
Start date
July 12, 2022
Completion date
October 31, 2023
Enrollment
24 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

immune surveillance